Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00185354Phase 3Completed
Phase 3, randomised, open-label trial of ethinyl estradiol + gestodene in contraception (2 arms), sponsored by Bayer. Primary endpoints: Bleeding pattern and cycle control and Number of pregnancies. Started Nov 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00185354.